Financhill
Back

Morphic Holding Quote, Financials, Valuation and Earnings

Morphic Holding Price Quote

$24.40
-0.01 (2.95%)
(Updated: December 2, 2023 at 4:12 AM ET)

Morphic Holding Key Stats

Sell
49
Morphic Holding (MORF) is a Sell

Day range:
$23.29 - $25.07
52-week range:
$19.35 - $63.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.10
P/B ratio:
1.68%

Volume:
657.4K
Avg. volume:
512.7K
1-year change:
-11.85%
Market cap:
$1.2B
Revenue:
$70.8M
EPS:
$-3.19

How Much Does Morphic Holding Make?

Data Unavailable

Is Morphic Holding Growing As A Company?

Data Unavailable

Morphic Holding Stock Price Performance

  • Did Morphic Holding Stock Go Up Last Month?
    Morphic Holding share price went up by 21.75% last month
  • Did MORF's Share Price Rise Over The Last Year?
    MORF share price fell by -11.85% over the past 1 year

What Is Morphic Holding 52-Week High & Low?

Morphic Holding Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Morphic Holding?

  • How Much Debt Does Morphic Holding Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Morphic Holding Have?
    Cash and short term investments quarterly total is $725.1M
  • What Is Morphic Holding’s Book Value Per Share?
    Book value per share is 14.54

Is Morphic Holding Cash Flow Positive?

  • What Is MORF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$108.9M
  • What Is Morphic Holding’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $454M
  • What Is Morphic Holding’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$355.8M

Morphic Holding Return On Invested Capital

Data Unavailable

Morphic Holding Earnings Date & Stock Price

Morphic Holding Competitors

  • Who Are Morphic Holding's Competitors?
    Below is a list of companies who compete with Morphic Holding or are related in some way:
    • Avalo Therapeutics Inc (AVTX)
    • Editas Medicine Inc (EDIT)
    • Flora Growth Corp (FLGC)
    • Myomo Inc (MYO)
    • SCYNEXIS Inc (SCYX)

Morphic Holding Dividend Yield

Data Unavailable

Morphic Holding Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 23.29%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 59.38
Upside from Last Price: 143.24%

Major Shareholders

  • How many MORF shares are owned by institutional investors?
    59.5M MORF shares are owned by institutional investors
  • How many MORF shares are owned by insiders?
    5M MORF shares are owned by insiders